中國生物製藥(01177.HK)組件營養類產品"素乾"獲特殊醫學用途配方食品註冊證
格隆匯 4 月 28日丨中國生物製藥(01177.HK))宣佈,集團的組件營養類產品"素乾"(特殊醫學用途碳水化合物組件配方食品)已通過國家市場監督管理總局的註冊審批,獲頒發特殊醫學用途配方食品註冊證。該產品主要成分為碳水化合物12.5g/100ml,適用於18歲以上擇期手術術前需要補充碳水化合物和水的人羣。
素乾是國內最早上市的口服碳水化合物(CHO)製劑,是基於加速康復外科(ERAS)理念而研發,為針對擇期手術患者術前使用的標準化口服碳水化合物產品,為中華醫學會外科學分會、中華醫學會麻醉學分會的《加速康復外科中國專家共識及路徑管理指南(2018版)》推薦使用。其作用包括:(1)增加患者術前能量儲備,減少術後併發症的發生;(2)術前預補充患者能量和水分,減少術中集中大量補液帶來的術後傷口癒合遲緩;(3)顯著緩解患者手術前的口渴、飢餓、焦慮等主觀不適,提高手術耐受力。
集團始終秉持健康大眾、惠澤天下的理念,在堅持開發尖端創新藥和生物藥的同時,致力於推動ERAS理念在國內的發展和實踐,戰略性開拓特醫食品市場。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.